Valve-in-valve transcatheter aortic valve implantation (TAVI): a new valuable approach to bioprosthetic infective endocarditis?
(2024) European heart journal. Case reports — Vol. 8, n° 8, p. ytae384 [1-2] (2024)
Files
2024_Kefer_Eur_Heart_J_Case_Rep.pdf
Open Access - Adobe PDF
- 293.15 KB
Details
- Authors
- Abstract
- A 77-year-old female patient was admitted for heart failure and severe aortic Magna Ease 21 mm bioprosthetic valve dysfunction (Figure 1A, Supplementary material online, Movie Image S1). Echocardiography revealed a vegetation on the right cusp of the bioprosthesis (Figure 1B, Supplementary material online, Movie Images S2 and S3), and blood cultures were positive for a Streptococcus sanguinis. Despite antibiotics (ceftriaxone followed by penicillin), stroke due to septic embolization occurred 3 days after the initial presentation. [...]
- Affiliations
Citations
Kefer, J., Vancraeynest, D., Roelants, V., & Belkhir, L. (2024). Valve-in-valve transcatheter aortic valve implantation (TAVI): a new valuable approach to bioprosthetic infective endocarditis? European heart journal. Case reports, 8(8), ytae384 [1-2]. https://doi.org/10.1093/ehjcr/ytae384 (Original work published 2024)